153:
lists the
Malaria Consortium's SMC program as one of its priority programs due to its high level of cost-effectiveness and ability to absorbe additional funding.
130:
for anti-inflammatory therapy. Chemoprophylaxis is also used to treat several different varieties of meningococcal infections for close contact exposure to
318:
76:
In some cases, chemoprophylaxis is initiated to prevent the spread of an existing infection in an individual to a new organ system, as when
253:
73:) to prevent recurrence. It may also refer to the administration of heparin to prevent deep venous thrombosis in hospitalized patients.
169:
cancer, by ‘using physiological mechanisms that do not kill healthy cells. Anand Reddi proposed a role for the antidiabetes drug
195:, in which measures are undertaken to prevent the onset of disease in individuals who are susceptible (as when patients receive
165:, seeks to identify ‘agents to reverse, suppress or prevent the carcinogenic process,’ from premalignancy to invasive and or
127:
302:
236:
141:
recommends chemoprevention to prevent
Malaria in the Sahel region of Sub-Saharan Africa through the use of the drugs
101:
The cost associated with chemoprophylaxis may be prohibitive, particularly when the cost of treatment is high or the
17:
350:
Sporn, Michael B (July 1976). "Approaches to prevention of epithelial cancer during the preneoplastic period".
123:
379:"Therapeutic potential of the anti-diabetic agent metformin in targeting the skin cancer stem cell diaspora"
422:
98:. In general, chemoprophylaxis should be initiated only when the benefits of treatment outweigh the risks.
427:
322:
142:
138:
102:
204:
70:
62:
269:
131:
292:
226:
95:
90:
The use of chemoprophylaxis is limited primarily by two factors: risk and financial costs.
8:
432:
149:. This technique is called Seasonal Malaria Chemoprevention (SMC). The charity evaluator
65:). Antibiotics may also be administered to healthy individuals to limit the spread of an
378:
336:
192:
106:
398:
359:
298:
273:
232:
390:
265:
162:
105:
of the target disease is low. Many forms of chemoprophylaxis are therefore not
416:
277:
54:
402:
119:
80:
363:
27:
Use of chemical compounds to prevent the development of a specific disease
186:
174:
146:
77:
50:
166:
84:
38:
394:
294:
Principles of
Pharmacology: The Pathophysiologic Basis of Drug Therapy
170:
58:
46:
150:
66:
196:
53:, for example, may be administered to patients with disorders of
42:
200:
225:
Woolf, Steven H.; Jonas, Steven; Kaplan-Liss, Evonne (2008),
118:
Using chemoprophylaxis as a treatment against early signs of
228:
Health
Promotion and Disease Prevention in Clinical Practice
377:
Reddi, Anand; Powers, Matthew; Devalle, Robert (May 2014).
337:"Malaria Consortium – Seasonal Malaria Chemoprevention"
231:, Lippincott Williams & Wilkins, pp. 346–358,
69:, or to patients who have repeated infections (such as
254:"Health Span Extension through Green Chemoprevention"
224:
319:"WHO | Seasonal malaria chemoprevention (SMC)"
376:
297:, Lippincott Williams & Wilkins, p. 578,
161:Chemoprevention in cancer, was first proposed by
414:
252:Fahey, Jed W.; Kensler, Thomas W. (2013-04-01).
218:
251:
94:All medications have the potential to cause
126:physicians observed polyps regression with
270:10.1001/virtualmentor.2013.15.4.stas1-1304
284:
14:
415:
349:
290:
113:
24:
37:refers to the administration of a
25:
444:
83:is administered in patients with
173:as a chemoprevention agent for
122:has proven to be effective. In
370:
343:
329:
311:
245:
124:familial adenomatous polyposis
87:to prevent further infection.
57:function to prevent bacterial
41:for the purpose of preventing
13:
1:
211:
203:to delay the development of
7:
180:
10:
449:
156:
143:sulfadoxine/pyrimethamine
139:World Health Organization
383:Experimental Dermatology
291:Golan, David E. (2008),
71:urinary tract infections
205:coronary artery disease
63:opportunistic infection
189:, a more general term.
132:Neisseria meningitidis
258:AMA Journal of Ethics
423:Medical terminology
428:Medical treatments
193:Primary prevention
395:10.1111/exd.12349
114:Specific diseases
16:(Redirected from
440:
407:
406:
374:
368:
367:
347:
341:
340:
333:
327:
326:
321:. Archived from
315:
309:
308:
288:
282:
281:
249:
243:
242:
222:
35:chemoprophylaxis
21:
448:
447:
443:
442:
441:
439:
438:
437:
413:
412:
411:
410:
375:
371:
352:Cancer Research
348:
344:
335:
334:
330:
325:on May 3, 2014.
317:
316:
312:
305:
289:
285:
250:
246:
239:
223:
219:
214:
183:
159:
116:
31:Chemoprevention
28:
23:
22:
18:Chemoprevention
15:
12:
11:
5:
446:
436:
435:
430:
425:
409:
408:
369:
342:
328:
310:
304:978-0781783552
303:
283:
264:(4): 311–318.
244:
238:978-0781775991
237:
216:
215:
213:
210:
209:
208:
190:
182:
179:
158:
155:
115:
112:
111:
110:
107:cost-effective
99:
61:(particularly
26:
9:
6:
4:
3:
2:
445:
434:
431:
429:
426:
424:
421:
420:
418:
404:
400:
396:
392:
388:
384:
380:
373:
365:
361:
357:
353:
346:
338:
332:
324:
320:
314:
306:
300:
296:
295:
287:
279:
275:
271:
267:
263:
259:
255:
248:
240:
234:
230:
229:
221:
217:
206:
202:
198:
194:
191:
188:
185:
184:
178:
176:
172:
168:
164:
163:Michael Sporn
154:
152:
148:
144:
140:
135:
133:
129:
125:
121:
108:
104:
100:
97:
93:
92:
91:
88:
86:
82:
79:
74:
72:
68:
64:
60:
56:
55:immune system
52:
48:
44:
40:
36:
32:
19:
386:
382:
372:
358:: 2699-702.
355:
351:
345:
331:
323:the original
313:
293:
286:
261:
257:
247:
227:
220:
160:
136:
120:tuberculosis
117:
96:side effects
89:
81:chemotherapy
75:
34:
30:
29:
187:Prophylaxis
175:skin cancer
147:amodiaquine
78:intrathecal
51:Antibiotics
433:Prevention
417:Categories
212:References
167:metastatic
85:malignancy
59:infections
39:medication
278:2376-6980
171:metformin
103:incidence
47:infection
403:24521225
181:See also
151:GiveWell
67:epidemic
364:1277177
201:statins
197:aspirin
43:disease
401:
362:
301:
276:
235:
157:Cancer
128:NSAIDs
389:(5).
399:PMID
360:PMID
299:ISBN
274:ISSN
233:ISBN
145:and
137:The
391:doi
266:doi
199:or
49:.
45:or
33:or
419::
397:.
387:23
385:.
381:.
356:36
354:.
272:.
262:15
260:.
256:.
207:).
177:.
134:.
405:.
393::
366:.
339:.
307:.
280:.
268::
241:.
109:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.